205 related articles for article (PubMed ID: 29217122)
1. Phase I-III development of the EORTC QLQ-ANL27, a health-related quality of life questionnaire for anal cancer.
Sodergren SC; Johnson CD; Gilbert A; Tomaszewski KA; Chu W; Chung HT; Dennis K; Desideri I; Glynne-Jones R; Grønlie Guren M; Kardamakis D; Nugent K; Schmidt H; Sebag-Montefiore D; Vassiliou V;
Radiother Oncol; 2018 Feb; 126(2):222-228. PubMed ID: 29217122
[TBL] [Abstract][Full Text] [Related]
2. International Validation of the EORTC QLQ-ANL27, a Field Study to Test the Anal Cancer-Specific Health-Related Quality-of-Life Questionnaire.
Sodergren SC; Johnson CD; Gilbert A; Darlington AS; Cocks K; Guren MG; Rivin Del Campo E; Brannan C; Christensen P; Chu W; Chung H; Dennis K; Desideri I; Gilbert DC; Glynne-Jones R; Jefford M; Johansson M; Johnsson A; Juul T; Kardamakis D; Lai-Kwon J; McFarlane V; Miguel IMC; Nugent K; Peters F; Riechelmann RP; Turhal NS; Wong S; Vassiliou V;
Int J Radiat Oncol Biol Phys; 2023 Apr; 115(5):1155-1164. PubMed ID: 36402360
[TBL] [Abstract][Full Text] [Related]
3. Development of the European Organisation for Research and Treatment of Cancer quality of life questionnaire module for older people with cancer: The EORTC QLQ-ELD15.
Johnson C; Fitzsimmons D; Gilbert J; Arrarras JI; Hammerlid E; Bredart A; Ozmen M; Dilektasli E; Coolbrandt A; Kenis C; Young T; Chow E; Venkitaraman R; Howse F; George S; O'Connor S; Yadegarfar G;
Eur J Cancer; 2010 Aug; 46(12):2242-52. PubMed ID: 20580993
[TBL] [Abstract][Full Text] [Related]
4. Development of a questionnaire (EORTC module) to measure quality of life in patients with cholangiocarcinoma and gallbladder cancer, the EORTC QLQ-BIL21.
Friend E; Yadegarfar G; Byrne C; Johnson CD; Sezer O; Pucciarelli S; Pereira SP; Chie WC; Banfield A; Ramage JK;
Br J Cancer; 2011 Feb; 104(4):587-92. PubMed ID: 21266979
[TBL] [Abstract][Full Text] [Related]
5. The EORTC QLQ-OH17: a supplementary module to the EORTC QLQ-C30 for assessment of oral health and quality of life in cancer patients.
Hjermstad MJ; Bergenmar M; Fisher SE; Montel S; Nicolatou-Galitis O; Raber-Durlacher J; Singer S; Verdonck-de Leeuw I; Weis J; Yarom N; Herlofson BB
Eur J Cancer; 2012 Sep; 48(14):2203-11. PubMed ID: 22572480
[TBL] [Abstract][Full Text] [Related]
6. Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancer. EORTC Study Group on Quality of Life.
Fitzsimmons D; Johnson CD; George S; Payne S; Sandberg AA; Bassi C; Beger HG; Birk D; Büchler MW; Dervenis C; Fernandez Cruz L; Friess H; Grahm AL; Jeekel J; Laugier R; Meyer D; Singer MW; Tihanyi T
Eur J Cancer; 1999 Jun; 35(6):939-41. PubMed ID: 10533475
[TBL] [Abstract][Full Text] [Related]
7. The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for patients with bone metastases: the EORTC QLQ-BM22.
Chow E; Hird A; Velikova G; Johnson C; Dewolf L; Bezjak A; Wu J; Shafiq J; Sezer O; Kardamakis D; van der Linden Y; Ma B; Castro M; Arnalot PF; Ahmedzai S; Clemons M; Hoskin P; Yee A; Brundage M; Bottomley A;
Eur J Cancer; 2009 May; 45(7):1146-1152. PubMed ID: 19097882
[TBL] [Abstract][Full Text] [Related]
8. Development of a questionnaire module to supplement the EORTC QLQ-C30 to assess quality of life in patients with hepatocellular carcinoma, the EORTC QLQ-HCC18.
Blazeby JM; Currie E; Zee BC; Chie WC; Poon RT; Garden OJ;
Eur J Cancer; 2004 Nov; 40(16):2439-44. PubMed ID: 15519517
[TBL] [Abstract][Full Text] [Related]
9. Cross-cultural development of an EORTC questionnaire to assess health-related quality of life in patients with testicular cancer: the EORTC QLQ-TC26.
Holzner B; Efficace F; Basso U; Johnson CD; Aaronson NK; Arraras JI; Smith AB; Chow E; Oberguggenberger AS; Bottomley A; Steiner H; Incrocci L; Giesinger JM
Qual Life Res; 2013 Mar; 22(2):369-78. PubMed ID: 22407356
[TBL] [Abstract][Full Text] [Related]
10. Development of a disease-specific health-related quality of life questionnaire (THYCA-QoL) for thyroid cancer survivors.
Husson O; Haak HR; Mols F; Nieuwenhuijzen GA; Nieuwlaat WA; Reemst PH; Huysmans DA; Toorians AW; van de Poll-Franse LV
Acta Oncol; 2013 Feb; 52(2):447-54. PubMed ID: 23013266
[TBL] [Abstract][Full Text] [Related]
11. Development of an EORTC disease-specific quality of life questionnaire for use in patients with liver metastases from colorectal cancer.
Kavadas V; Blazeby JM; Conroy T; Sezer O; Holzner B; Koller M; Buckels J;
Eur J Cancer; 2003 Jun; 39(9):1259-63. PubMed ID: 12763214
[TBL] [Abstract][Full Text] [Related]
12. Danish translation and pilot testing of the European Organization for Research and Treatment of Cancer QLQ-TC 26 (EORTC QLQ-TC26) questionnaire to assess health-related quality of life in patients with testicular cancer.
Bager L; Elsbernd A; Nissen A; Daugaard G; Pappot H
Health Qual Life Outcomes; 2018 Jun; 16(1):128. PubMed ID: 29914500
[TBL] [Abstract][Full Text] [Related]
13. International development of four EORTC disease-specific quality of life questionnaires for patients with Hodgkin lymphoma, high- and low-grade non-Hodgkin lymphoma and chronic lymphocytic leukaemia.
van de Poll-Franse L; Oerlemans S; Bredart A; Kyriakou C; Sztankay M; Pallua S; Daniëls L; Creutzberg CL; Cocks K; Malak S; Caocci G; Molica S; Chie W; Efficace F;
Qual Life Res; 2018 Feb; 27(2):333-345. PubMed ID: 29127596
[TBL] [Abstract][Full Text] [Related]
14. Development of a disease-specific health-related quality of life (HRQoL) questionnaire intended to be used in conjunction with the general European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ) in renal cell carcinoma patients.
Beisland E; Aarstad HJ; Aarstad AK; Bakke A; Bostad L; Beisland C
Acta Oncol; 2016; 55(3):349-56. PubMed ID: 26251300
[TBL] [Abstract][Full Text] [Related]
15. The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life.
Bergman B; Aaronson NK; Ahmedzai S; Kaasa S; Sullivan M
Eur J Cancer; 1994; 30A(5):635-42. PubMed ID: 8080679
[TBL] [Abstract][Full Text] [Related]
16. Development of an EORTC questionnaire module to be used in health-related quality-of-life assessment for patients with multiple myeloma. European Organization for Research and Treatment of Cancer Study Group on Quality of Life.
Stead ML; Brown JM; Velikova G; Kaasa S; Wisløff F; Child JA; Hippe E; Hjorth M; Sezer O; Selby P
Br J Haematol; 1999 Mar; 104(3):605-11. PubMed ID: 10086801
[TBL] [Abstract][Full Text] [Related]
17. International field testing of the psychometric properties of an EORTC quality of life module for oral health: the EORTC QLQ-OH15.
Hjermstad MJ; Bergenmar M; Bjordal K; Fisher SE; Hofmeister D; Montel S; Nicolatou-Galitis O; Pinto M; Raber-Durlacher J; Singer S; Tomaszewska IM; Tomaszewski KA; Verdonck-de Leeuw I; Yarom N; Winstanley JB; Herlofson BB;
Support Care Cancer; 2016 Sep; 24(9):3915-24. PubMed ID: 27113466
[TBL] [Abstract][Full Text] [Related]
18. International phase IV validation study of an EORTC quality of life questionnaire for testicular cancer patients: the EORTC QLQ-TC26.
Sztankay M; Aaronson NK; Arraras JI; Basso U; Bumbasirevic U; Efficace F; Giesinger JM; Johnson CD; van Leeuwen M; Oberguggenberger AS; Sosnowski R; Young T; Holzner B;
BMC Cancer; 2018 Nov; 18(1):1104. PubMed ID: 30419889
[TBL] [Abstract][Full Text] [Related]
19. Cross-cultural development of a quality-of-life measure for patients with melanoma: phase 3 testing of an EORTC Melanoma Module.
Winstanley JB; Young TE; Boyle FM; Bergenmar M; Bottomley A; Burmeister B; Campana LG; Garioch JJ; King M; Nikolic DV; van de Poll-Franse LV; Saw R; Thompson JF; White EG;
Melanoma Res; 2015 Feb; 25(1):47-58. PubMed ID: 25325247
[TBL] [Abstract][Full Text] [Related]
20. An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45.
Bjelic-Radisic V; Cardoso F; Cameron D; Brain E; Kuljanic K; da Costa RA; Conroy T; Inwald EC; Serpentini S; Pinto M; Weis J; Morag O; Lindviksmoen Astrup G; Tomaszweksi KA; Pogoda K; Sinai P; Sprangers M; Aaronson N; Velikova G; Greimel E; Arraras J; Bottomley A;
Ann Oncol; 2020 Feb; 31(2):283-288. PubMed ID: 31959345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
